Drug
Hetrombopag Olamine
Hetrombopag Olamine: highest development phase Phase 3, developed by Jiangsu Hengrui Medicine. 2 trial records tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Jiangsu Hengrui Medicine
Trials
| Drug | Phase | Indication |
|---|---|---|
| Hetrombopag Olamine NCT07286032 | Phase 3 | Patients With Chemotherapy-Induced Thrombocytopenia |
| Hetrombopag Olamine Tablets NCT01830660 | Phase 1 | Healthy |
Latest
Follow Hetrombopag Olamine on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.